Cargando…

Long-term depression links amyloid-β to the pathological hyperphosphorylation of tau

In Alzheimer’s disease, soluble oligomers of the amyloid-β peptide (Aβ(o)) trigger a cascade of events that includes abnormal hyperphosphorylation of the protein tau, which is essential for pathogenesis. However, the mechanistic link between these two key pathological proteins remains unclear. Using...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Henry B.C., Emptage, Nigel J., Jeans, Alexander F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424646/
https://www.ncbi.nlm.nih.gov/pubmed/34469725
http://dx.doi.org/10.1016/j.celrep.2021.109638
Descripción
Sumario:In Alzheimer’s disease, soluble oligomers of the amyloid-β peptide (Aβ(o)) trigger a cascade of events that includes abnormal hyperphosphorylation of the protein tau, which is essential for pathogenesis. However, the mechanistic link between these two key pathological proteins remains unclear. Using hippocampal slices, we show here that an Aβ(o)-mediated increase in glutamate release probability causes enhancement of synaptically evoked N-methyl-d-aspartate subtype glutamate receptor (NMDAR)-dependent long-term depression (LTD). We also find that elevated glutamate release probability is required for Aβ(o)-induced pathological hyperphosphorylation of tau, which is likewise NMDAR dependent. Finally, we show that chronic, repeated chemical or optogenetic induction of NMDAR-dependent LTD alone is sufficient to cause tau hyperphosphorylation without Aβ(o). Together, these results support a possible causal chain in which Aβ(o) increases glutamate release probability, thus leading to enhanced LTD induction, which in turn drives hyperphosphorylation of tau. Our data identify a mechanistic pathway linking the two critical pathogenic proteins of AD.